Clinical Trial Update: Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of RAS(ON) inhibitors in combination with Ivonescimab is currently recruiting in patients with solid tumors, including non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Ivonescimab (AK112/SMT112)
• RAS(ON) inhibitors

Snippet

Sponsor: Revolution Medicines, Inc. | Conditions: Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING